Evidence map›Paper›PMID 35426501›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2022

A20 attenuates pyroptosis and apoptosis in nucleus pulposus cells via promoting mitophagy and stabilizing mitochondrial dynamics.

Xin Peng, Cong Zhang, Zhi-Min Zhou, Kun Wang, Jia-Wei Gao, Zhan-Yang Qian, Jun-Ping Bao, Hang-Yu Ji, V L F Cabral, Xiao-Tao Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Autophagy regulation of pyroptosis and ferroptosis: a new strategy for colorectal cancer treatment.Apoptosis : an international journal on programmed cell death · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Xin Peng *Medical School of Southeast University, Nanjing, China.
Cong Zhang *Department of Orthopedics, Zhongda Hospital, Southeast University, Nanjing, China.
Zhi-Min Zhou *Department of Orthopedics, Zhongda Hospital, Southeast University, Nanjing, China.
Kun WangDepartment of Orthopedics, Zhongda Hospital, Southeast University, Nanjing, China.
Jia-Wei GaoMedical School of Southeast University, Nanjing, China.
Zhan-Yang QianMedical School of Southeast University, Nanjing, China.
Jun-Ping BaoMedical School of Southeast University, Nanjing, China.
Hang-Yu JiDepartment of Orthopedics, Zhongda Hospital, Southeast University, Nanjing, China.
V L F CabralMedical School of Southeast University, Nanjing, China.
Xiao-Tao WuMedical School of Southeast University, Nanjing, China. wuxiaotaospine@seu.edu.cn.ORCID http://orcid.org/0000-0003-1974-8193
Southeast University · CNZhongda Hospital Southeast University · CNSoutheast University · BD

Funding

National Natural Science Foundation of China 81702201National Natural Science Foundation of China 81871810
6 · The paper itself

Abstract

backgroundA20 is an anti-inflammatory molecule in nucleus pulposus (NP) cells. The anti-inflammatory properties of A20 are mainly attributed to its ability to suppress the NF-κB pathway. However, A20 can protect cells from death independently of NF-κB regulation. This study aimed to investigate the effects of A20 on pyroptosis and apoptosis of NP cells induced by lipopolysaccharide (LPS).

methodsNP cells induced by LPS were used as an in vitro model of the inflammatory environment of the intervertebral disc. Pyroptosis, apoptosis, and mitophagy marker proteins were detected. Then, NP cells were transfected with A20 overexpressed lentivirus or A20-siRNA. Annexin V FITC/PI, Western blotting, and immunofluorescence assays were used to detect the apoptosis, pyroptosis, and mitophagy of NP cells. Furthermore, the expressions of A20, related proteins, and related inflammatory cytokines were detected by western blotting, and ELISA.

resultsApoptosis and pyroptosis of NP cells increased gradually treated with LPS for 12 h, 24 h, and 48 h. Differently, the level of mitophagy increased first and then decreased, and was the highest at LPS treatment for 12 h. Overexpression or knockdown of A20 in NP cells revealed that A20 attenuated the pyroptosis, apoptosis, and production of inflammatory cytokines of NP cells induced by LPS, while A20 sponsored mitophagy, reduced ROS production and collapse of mitochondrial membrane potential (ΔΨm). Moreover, A20 also promoted mitochondrial dynamic homeostasis and attenuated LPS-induced excessive mitochondrial fission. Excitingly, inhibition of mitophagy attenuated the effect of A20 on the negative regulation of pyroptosis of NP cells induced by LPS. Pyroptosis was accompanied by a large release of inflammatory cytokines. Inhibition of pyroptosis also significantly reduced apoptosis of NP cells. Finally, The mitochondria-targeted active peptide SS-31 inhibited LPS-induced pyroptosis and ROS production in NP cells.

conclusionsTo sum up, A20 attenuates pyroptosis and apoptosis of NP cells via promoting mitophagy and stabilizing mitochondrial dynamics. Besides, A20 reduces LPS-induced NP cell apoptosis by inhibiting NLRP3 inflammasome-mediated pyroptosis. It provides theoretical support for the reduction of functional NP cell loss in the intervertebral disc through the gene-targeted intervention of A20.

Indexed as

Nucleus PulposusAnti-Inflammatory AgentsApoptosisCytokinesLipopolysaccharidesMitochondrial DynamicsMitophagyNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisReactive Oxygen SpeciesAnti-Inflammatory AgentsCytokinesLipopolysaccharidesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesA20InflammationMitophagyNLRP3Nucleus pulposusROS

Identifiers

PMID35426501
OpenAlexW4223894575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.